|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
4/2002
vol. 1 abstract:
Clinical efficacy and tolerance of oral low-dose continuous estrogen-progestin therapy (Activelle)
Edyta Wlaźlak
,
Grzegorz Surkont
,
Jacek Suzin
(Prz Menopauz 2002; 4: 35–38)
Online publish date: 2004/03/03
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
New therapeutical option for hrt – oral low-dose continuous estrogen-progestin therapy with the use of 1 mg estradiol and 0.5 mg norethisterone acetate was evaluated in the article. We find Activelle (Novo Nordisk) effective in the treatment of menopausal symptoms. This drug is well tolerated by postmenopausal women. The frequency of side effects is low. The most common is spotting/bleeding: 22.6% patients in the first month of hrt, 6.9% treated women after 6 months.
keywords:
menopause, low-dose hrt |
 |
